DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO
Respiree announced today that it has incorporated in the US and will be incubating within Johnson & Johnson Innovation – JLABS @ South San Francisco[1] from February 12, 2024. By expanding footprint within the US, Respiree aims to deepen its relationships and networks…
Curavit Successfully Completes a Virtual Clinical Trial for Sana’s Investigative Digital Therapeutic to Treat Symptoms of PTSD
Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) for digital therapeutics (DTx), has successfully completed a decentralized trial for the Sana Device. Sana has submitted the trial data for Breakthrough Device Designation consideration from the U.S….
